Messerli FH - Search Results

1

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.

Pepine CJ, Handberg EM, Cooper-DeHoff RM, Marks RG, Kowey P, Messerli FH, Mancia G, Cangiano JL, Garcia-Barreto D, Keltai M, Erdine S, Bristol HA, Kolb HR, Bakris GL, Cohen JD, Parmley WW; INVEST Investigators. Pepine CJ, et al. Among authors: messerli fh. JAMA. 2003 Dec 3;290(21):2805-16. doi: 10.1001/jama.290.21.2805. JAMA. 2003. PMID: 14657064 Clinical Trial.

2

Sublingual nifedipine for hypertensive emergencies.

Messerli FH, Kowey P, Grodzicki T. Messerli FH, et al. Lancet. 1991 Oct 5;338(8771):881. doi: 10.1016/0140-6736(91)91530-8. Lancet. 1991. PMID: 1681227 No abstract available.

3

The TPA controversy and the drug approval process. The view of the Cardiovascular and Renal Drugs Advisory Committee.

Kowey PR, Fisher L, Giardina EG, Leier CV, Lowenthal DT, Messerli FH, Pratt CM. Kowey PR, et al. Among authors: messerli fh. JAMA. 1988 Oct 21;260(15):2250-2. JAMA. 1988. PMID: 3139900 Review. No abstract available.

4

Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies?

Grossman E, Messerli FH, Grodzicki T, Kowey P. Grossman E, et al. Among authors: messerli fh. JAMA. 1996 Oct 23-30;276(16):1328-31. JAMA. 1996. PMID: 8861992 Review.

5

Calcium antagonists and cardiovascular prognosis: a homogeneous group?

Laragh JH, Held C, Messerli F, Pepine C, Sleight P. Laragh JH, et al. Am J Hypertens. 1996 Feb;9(2):99-109. doi: 10.1016/0895-7061(95)00416-5. Am J Hypertens. 1996. PMID: 8924271 Review. No abstract available.

6

The Lanai Symposium: hypertensive patient profiles: approaches to management and disease prevention.

Bakris GL, Messerli FH. Bakris GL, et al. Among authors: messerli fh. J Hum Hypertens. 1997 Jan;11(1):7-8. doi: 10.1038/sj.jhh.1000393. J Hum Hypertens. 1997. PMID: 9111150 No abstract available.

7

Effects of verapamil and trandolapril in the treatment of hypertension. Trandolapril Study Group.

Messerli F, Frishman WH, Elliott WJ. Messerli F, et al. Am J Hypertens. 1998 Mar;11(3 Pt 1):322-7. doi: 10.1016/s0895-7061(97)00466-4. Am J Hypertens. 1998. PMID: 9544873 Clinical Trial.

8

Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review.

Messerli FH, Grossman E, Goldbourt U. Messerli FH, et al. JAMA. 1998 Jun 17;279(23):1903-7. doi: 10.1001/jama.279.23.1903. JAMA. 1998. PMID: 9634263

9

Implications of a health lifestyle and medication analysis for improving hypertension control.

Weir MR, Maibach EW, Bakris GL, Black HR, Chawla P, Messerli FH, Neutel JM, Weber MA. Weir MR, et al. Among authors: messerli fh. Arch Intern Med. 2000 Feb 28;160(4):481-90. doi: 10.1001/archinte.160.4.481. Arch Intern Med. 2000. PMID: 10695688

10

Clinical outcomes in the diabetes cohort of the INternational VErapamil SR-Trandolapril study.

Bakris GL, Gaxiola E, Messerli FH, Mancia G, Erdine S, Cooper-DeHoff R, Pepine CJ; INVEST Investigators. Bakris GL, et al. Among authors: messerli fh. Hypertension. 2004 Nov;44(5):637-42. doi: 10.1161/01.HYP.0000143851.23721.26. Epub 2004 Sep 20. Hypertension. 2004. PMID: 15381674

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

765 results

Search Page